The central executioners of apoptosis: caspases or mitochondria?

被引:678
作者
Green, D
Kroemer, G
机构
[1] La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA
[2] CNRS, UPR 420, F-94801 Villejuif, France
基金
美国国家卫生研究院; 澳大利亚研究理事会;
关键词
D O I
10.1016/S0962-8924(98)01273-2
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Apoptosis is a type of cell death whose morphological appearance relies on the activation of caspase-family cysteine proteases. Recently, it has become clear that inhibition of caspases does not always prevent irreversible loss of cellular function, although if does prevent the acquisition of apoptotic morphology. Alterations in mitochondrial membrane structure ann function can occur in a caspase-independent fashion and have a higher predictive value for cell death than caspase activation. Here, Douglas Green and Guide Kroemer argue that caspases might have a dual function in the apoptotic process: first, as signal-transduction molecules that act as facultative induces of mitochondrial membrane changes, and, second, as processing enzymes that orchestrate the apoptotic phenotype. They propose a model for initiation of apoptosis in which mitochondria ann caspases engage in a self-amplifying pathway of mutual activation.
引用
收藏
页码:267 / 271
页数:5
相关论文
共 45 条
  • [1] Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death
    Amarante-Mendes, GP
    Finucane, DM
    Martin, SJ
    Cotter, TG
    Salvesen, GS
    Green, DR
    [J]. CELL DEATH AND DIFFERENTIATION, 1998, 5 (04) : 298 - 306
  • [2] BERNARDI P, 1996, BIOCHIM BIOPHYS ACTA, V275, P5
  • [3] Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation
    Boise, LH
    Thompson, CB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) : 3759 - 3764
  • [4] Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization
    Bossy-Wetzel, E
    Newmeyer, DD
    Green, DR
    [J]. EMBO JOURNAL, 1998, 17 (01) : 37 - 49
  • [5] Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers
    Brunet, CL
    Gunby, RH
    Benson, RSP
    Hickman, JA
    Watson, AJM
    Brady, G
    [J]. CELL DEATH AND DIFFERENTIATION, 1998, 5 (01) : 107 - 115
  • [6] Cyclosporin A-sensitive release of Ca2+ from mitochondria in intact thymocytes
    Chernyak, BV
    [J]. FEBS LETTERS, 1997, 418 (1-2) : 131 - 134
  • [7] Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway
    Dbaibo, GS
    Perry, DK
    Gamard, CJ
    Platt, R
    Poirier, GG
    Obeid, LM
    Hannun, YA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) : 481 - 490
  • [8] Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis
    DeMaria, R
    Lenti, L
    Malisan, F
    dAgostino, F
    Tomassini, B
    Zeuner, A
    Rippo, MR
    Testi, R
    [J]. SCIENCE, 1997, 277 (5332) : 1652 - 1655
  • [9] Ellerby HM, 1997, J NEUROSCI, V17, P6165
  • [10] ENARI M, 1995, EMBO J, V14, P5201, DOI 10.1002/j.1460-2075.1995.tb00204.x